| Entry |
|
| Name |
Nicotine polacrilex (USP); Nicorette (TN) |
| Class |
Neuropsychiatric agent
DG01715 Drugs for nicotine dependence
Metabolizing enzyme substrate
DG01638 CYP2A6 substrate
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
|
| Remark |
| Product (DG00994): | D03365<JP/US> |
|
| Efficacy |
Smoking cessation adjunct |
| Target |
|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
| Metabolism |
Enzyme: CYP2A6 [HSA: 1548]
|
| Interaction |
CYP induction: CYP1A2 [HSA: 1544]
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07B DRUGS USED IN ADDICTIVE DISORDERS
N07BA Drugs used in nicotine dependence
N07BA01 Nicotine
D05157 Nicotine polacrilex (USP)
USP drug classification [BR:br08302]
Anti-Addiction/Substance Abuse Treatment Agents
Smoking Cessation Agents
Nicotine
D05157 Nicotine polacrilex (USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01715 Drugs for nicotine dependence
DG00994 Nicotine
D05157 Nicotine polacrilex
Metabolizing enzyme substrate
DG01638 CYP2A6 substrate
DG00994 Nicotine
D05157 Nicotine polacrilex
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
DG00994 Nicotine
D05157 Nicotine polacrilex
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Acetylcholine (nicotinic)
CHRN
D05157 Nicotine polacrilex (USP)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D05157
Rx-to-OTC switch list in the USA [br08315.html]
D05157
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01715 Drugs for nicotine dependence
DG00994 Nicotine
Metabolizing enzyme substrate
DG01638 CYP2A6 substrate
DG00994 Nicotine
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
DG00994 Nicotine
|
| Other DBs |
|
| LinkDB |
|